Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010050
Filing Date
2025-04-03
Accepted
2025-04-03 18:05:40
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032025_100437.html 4  
1 form4-04032025_100437.xml 4 5638
  Complete submission text file 0001415889-25-010050.txt   7272
Mailing Address C/O THRESHOLD PHARMACEUTICALS, INC. 1300 SEAPORT BOULEVARD, 5TH FLOOR REDWOOD CITY CA 94063
Business Address
Colowick Alan (Reporting) CIK: 0001316163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 25811319

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)